|
 |
Volume 3, Number 5 (May 2006) | |||||
Letter from the Editor |
|||||
234 |
Taking the team approach The West Clinic, Memphis, TN Contributors to this issue reflect the makeup of the multidisciplinary teams that cancer patients expect and deserve for their treatment. Our featured topic, breast cancer, is a good model for that approach.
|
||||
Community Dialogue |
|||||
241 |
The new focus on accountability Dr. Reeves talks with us about accountability, fairness, and transparency—and why he thinks oncologists will no longer be brokers for chemotherapy agents.
|
||||
Original Contribution |
|||||
259 |
The impact of first and subsequent cycle pegfilgrastim on neutropenic events in patients receiving myelosuppressive chemotherapy in community practice: interim results of the prospective FIRST study University of Oklahoma Cancer Center, Oklahoma City, OK, and Amgen Inc., Thousand Oaks, CA To gain additional experience in the community practice setting, the authors conducted a large, prospective study in patients with cancer receiving myelotoxic chemotherapy and pegfilgrastim support in all cycles.
|
||||
Challenging Cases/Rare Cancers |
|||||
266 |
Duodenal somatostatinoma and gastrointestinal stromal tumor associated with neurofibromatosis Departments of Surgery, Oncology, Pathology, and Radiology, The Joan Karnell Cancer Center, Pennsylvania Hospital, Philadelphia, PA Somatostatinomas, a rare form of a malignant neuroendocrine tumor, are found with increasing frequency in patients with neurofibromatosis type 1 and GISTs.
|
||||
Controversies in Patient Management |
|||||
275 |
Reducing the risk of recurrence in postmenopausal women with early breast cancer: a role for aromatase inhibitors Fairfax-Northern Virginia Hematology-Oncology, Fairfax, VA Aromatase inhibitors offer improved outcomes over tamoxifen and should be considered as front-line adjuvant hormonal treatment or given sequentially following a course of tamoxifen therapy.
|
||||
Economics/Practice Management |
|||||
284 |
Board-certified oncology pharmacists: partners in the multidisciplinary care of cancer patients Specialty Council on Oncology Pharmacy, Medical Science Liaison, Millennium Pharmaceuticals, Inc, Cambridge, MA, Specialty Council on Oncology Pharmacy; University of California Davis Medical Center, Sacramento, CA, and Board of Pharmaceutical Specialties, Washington, DC Including an oncology pharmacy clinical specialist on the treatment team for cancer patients improves outcomes, reduces the length of hospital stays, reduces medication errors, and lowers costs.
|
||||
Quality Care |
|||||
295 |
Better communication with minority patients: seven strategies for achieving cultural competency Blue Cross and Blue Shield of Florida, Jacksonville, FL Cultural and ethnic differences present barriers to quality care. These barriers revolve, in part, around inadequate communication with minority populations. This article offers specific strategies for surmounting those barriers.
|
||||
Managing Side Effects |
|||||
304 |
Managing lymphedema, a lingering problem for breast cancer patients Memorial Sloan-Kettering Cancer Center, New York, NY The prospect of lymphedema provokes substantial anxiety for many patients with breast cancer. This condition is a chronic problem that is time-consuming to manage, often resulting in dramatic life changes. The author suggests ways to help patients both prevent and treat lymphedema.
|
||||
Psychosocial Oncology |
|||||
311 |
Emotional distress in patients with cancer: the sixth vital sign University of Calgary, Calgary, Alberta, Canada, and Memorial Sloan-Kettering Cancer Center, New York, NY As the incidence of cancer continues to rise, so too will the rate of emotional distress in cancer patients. There are both clinical and economic benefits to addressing the psychosocial needs of these patients.
|
||||
Brief Communications |
|||||
246 |
Detecting asymptomatic endometrial carcinoma by combined PET/CT Harrington Cancer Center, Texas Tech University Health Sciences Center, Amarillo, TX
| ||||
Legal Matters |
|||||
289 |
Ask your lawyer Philadelphia, PA Thinking of buying an MRI for the office, expanding your types of lab tests, or investing in a nearby imaging center where you can send your patients? First, you’ll need legal advice about conflicts of interest in a practice.
| ||||
Technology |
|||||
301 |
Feeding your software-hungry PDA As a follow-up to our April 2006 issue, here are some more programs to consider for your PDA, all to help you grapple with the medical decisions you have to make each day.
| ||||
Washington Update |
|||||
317 |
Facing reality: cancer clinics and the full impact of MMA Community Oncology Alliance, Washington, DC The Community Oncology Alliance has championed a number of initiatives on various fronts to help private practitioners do what they do best: offer quality care to cancer patients in a low-cost setting.
|
||||
© 2006 by Elsevier Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the publisher. |
|||||
43 kb